Study summary

The objective of this study is to evaluate the efficacy, safety and pharmacokinetics of ASP5094 in patients with rheumatoid arthritis (RA) treated with background methotrexate (MTX).

Additional Study Details

Phase
2
Product
  • ASP5094
  • Placebo
  • Type
    Interventional
    Masking
    Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
    Enrollment number
    66
    Show Additional Study Details

    Study documents

    Scientific Results Summary
    Available Language(s): English
    Plain Language Summary
    Available Language(s): English

    Get more information

    Would you like more information about clinical trial sites that are recruiting participants for A study to evaluate the efficacy and safety of ASP5094 in patients with Rheumatoid Arthritis on methotrexate? Contact us by filling out your information to the right and we’ll respond to you.

    • A patient
    • A caregiver
    • A parent
    • A healthcare provider
    • A patient advocate
    • Algeria
    • Argentina
    • Armenia
    • Australia
    • Austria
    • Belarus
    • Belgium
    • Bosnia And Herzegovina
    • Brazil
    • Bulgaria
    • Canada
    • Chile
    • China
    • Colombia
    • Croatia
    • Czech Republic
    • Denmark
    • Dominican Republic
    • Egypt
    • Estonia
    • Finland
    • Former Serbia and Montenegro
    • France
    • Georgia
    • Germany
    • Greece
    • Guatemala
    • Hong Kong
    • Hungary
    • Iceland
    • India
    • Indonesia
    • Ireland
    • Israel
    • Italy
    • Japan
    • Jordan
    • Kazakhstan
    • Latvia
    • Lebanon
    • Lithuania
    • Macedonia
    • Malaysia
    • Mexico
    • Montenegro
    • Morocco
    • Netherlands
    • New Zealand
    • Norway
    • Panama
    • Peru
    • Philippines
    • Poland
    • Portugal
    • Puerto Rico
    • Republic of Korea
    • Republic of Moldova
    • Romania
    • Russian Federation
    • Saudi Arabia
    • Serbia
    • Singapore
    • Slovakia
    • Slovenia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Taiwan, Province of China
    • Thailand
    • Turkey
    • Ukraine
    • United Kingdom
    • United States
    • Vietnam

    By clicking ["Continue/Submit"], you agree that Astellas may contact you by email with information to help you connect with clinical trial sites. While we can connect you to clinical trial sites, we cannot answer questions about any investigational therapy through email. Your consent to receiving emails is not a requirement to participate in a clinical trial or study. For more information, including how to unsubscribe at any time, see our Privacy Notice & Cookies Policy.

      Locations

      Contact Us
      Contact Us
      Completed
      Site JP00024
      Tsukuba, Japan
      Completed
      Site JP00018
      Meguro, Japan
      Completed
      Site JP00012
      Kanuma, Japan
      Completed
      Site JP00008
      Fukuoka, Japan
      Completed
      Site JP00031
      Yokohama, Japan
      Completed
      Site JP00006
      Kyoto, Japan
      Completed
      Site JP00025
      Kobe, Japan
      Completed
      Site JP00020
      Nagano, Japan
      Completed
      Site JP00017
      Tomakomai, Japan
      Completed
      Site JP00001
      Sapporo, Japan
      Completed
      Site JP00013
      Toyohashi, Japan
      Completed
      Site JP00004
      Takasaki, Japan
      Completed
      Site JP00002
      Asahikawa, Japan
      Completed
      Site JP00011
      Oita, Japan
      Completed
      Site JP00009
      Fukuoka, Japan
      Completed
      Site JP00027
      Asahikawa, Japan
      Completed
      Site JP00010
      Kumamoto, Japan
      Completed
      Site JP00007
      Sanuki, Japan
      Completed
      Site JP00019
      Sagamihara, Japan
      Completed
      Site JP00016
      Ichinomiya, Japan
      Completed
      Site JP00023
      Shimonoseki, Japan
      Completed
      Site JP00026
      Fukuoka, Japan
      Completed
      Site JP00015
      Chiba, Japan
      Completed
      Site JP00014
      Nagoya, Japan
      Completed
      Site JP00003
      Osaki, Japan
      Completed
      Site JP00028
      Kawachinagano, Japan
      Completed
      Site JP00022
      Okayama, Japan
      Completed
      Site JP00029
      Beppu, Japan
      Completed
      Site JP00030
      Kobe, Japan
      Completed
      Site JP00021
      Shizuoka, Japan
      Completed
      Site JP00005
      Kitamoto, Japan

      Frequently Asked Questions

      Are clinical trials only for people with advanced cancer?

      While some clinical trials may focus on more advanced cancers, many trials are open to patients at various stages of their cancer. Each study has rules about who can take part. For example, only patients in a certain age group or those who have a certain type of tumor may be able to join.

      Will I have to stop my current treatment to participate in a clinical trial?

      Sometimes researchers want participants to keep taking their current treatments during a clinical trial. Other times, you may need to stop your current treatments for a while. If the investigational treatment doesn't work, you can usually go back to your original treatment plan.

      Should I be worried about getting a placebo?

      In cancer clinical trials, a placebo is only used if there is no other treatment for that type of cancer. This helps compare an investigational treatment to the placebo. Placebos are rarely used in cancer trials because the best available treatment, called the “standard of care”, is usually given instead.

      Do I need a referral from my doctor to take part in a study?

      Your doctor may not know about all the opportunities for clinical trials that are available to you. Talk to your doctor or other medical provider about clinical trial information that you find. They can help you decide if a clinical trial is right for you. If you do not find any options on this website, we recommend you visit an online public registry website like clinicaltrials.gov to see a wide variety of available clinical trials.

      Explore More

      1

      What are clinical trials?

      2

      Why are Clinical Trials Important?

      3

      Why Participate in a Clinical Trial?